173 related articles for article (PubMed ID: 2913914)
1. Calcitriol treatment is not effective in postmenopausal osteoporosis.
Ott SM; Chesnut CH
Ann Intern Med; 1989 Feb; 110(4):267-74. PubMed ID: 2913914
[TBL] [Abstract][Full Text] [Related]
2. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.
Gallagher JC; Goldgar D
Ann Intern Med; 1990 Nov; 113(9):649-55. PubMed ID: 2221645
[TBL] [Abstract][Full Text] [Related]
3. Calcitriol in the treatment of postmenopausal osteoporosis.
Aloia JF; Vaswani A; Yeh JK; Ellis K; Yasumura S; Cohn SH
Am J Med; 1988 Mar; 84(3 Pt 1):401-8. PubMed ID: 3279769
[TBL] [Abstract][Full Text] [Related]
4. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.
Ebeling PR; Wark JD; Yeung S; Poon C; Salehi N; Nicholson GC; Kotowicz MA
J Clin Endocrinol Metab; 2001 Sep; 86(9):4098-103. PubMed ID: 11549632
[TBL] [Abstract][Full Text] [Related]
5. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.
Jensen GF; Meinecke B; Boesen J; Transbøl I
Clin Orthop Relat Res; 1985; (192):215-21. PubMed ID: 3881203
[TBL] [Abstract][Full Text] [Related]
6. Treatment of postmenopausal osteoporosis with calcitriol or calcium.
Tilyard MW; Spears GF; Thomson J; Dovey S
N Engl J Med; 1992 Feb; 326(6):357-62. PubMed ID: 1729617
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with calcitriol in postmenopausal osteoporosis.
Caniggia A; Nuti R; Lore F; Martini G; Turchetti V; Righi G
Metabolism; 1990 Apr; 39(4 Suppl 1):43-9. PubMed ID: 2325571
[TBL] [Abstract][Full Text] [Related]
8. Role of calcitriol in the treatment of postmenopausal osteoporosis.
Aloia JF
Metabolism; 1990 Apr; 39(4 Suppl 1):35-8. PubMed ID: 2182976
[TBL] [Abstract][Full Text] [Related]
9. Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action.
Chesnut CH; Ivey JL; Gruber HE; Matthews M; Nelp WB; Sisom K; Baylink DJ
Metabolism; 1983 Jun; 32(6):571-80. PubMed ID: 6341772
[TBL] [Abstract][Full Text] [Related]
10. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
11. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
Jones G; Hogan DB; Yendt E; Hanley DA
CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
[TBL] [Abstract][Full Text] [Related]
12. Low-dose calcitriol versus calcium in established postmenopausal osteoporosis.
Tilyard M
Metabolism; 1990 Apr; 39(4 Suppl 1):50-2. PubMed ID: 2325572
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis.
Gallagher JC
Metabolism; 1990 Apr; 39(4 Suppl 1):27-9. PubMed ID: 2325568
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
Greenspan SL; Bone HG; Ettinger MP; Hanley DA; Lindsay R; Zanchetta JR; Blosch CM; Mathisen AL; Morris SA; Marriott TB;
Ann Intern Med; 2007 Mar; 146(5):326-39. PubMed ID: 17339618
[TBL] [Abstract][Full Text] [Related]
16. Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.
Dechant KL; Goa KL
Drugs Aging; 1994 Oct; 5(4):300-17. PubMed ID: 7827399
[TBL] [Abstract][Full Text] [Related]
17. Effects of a combined alendronate and calcitriol agent (Maxmarvil) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study.
Rhee Y; Kang M; Min Y; Byun D; Chung Y; Ahn C; Baek K; Mok J; Kim D; Kim D; Kim H; Kim Y; Myoung S; Kim D; Lim SK
Osteoporos Int; 2006 Dec; 17(12):1801-7. PubMed ID: 17019520
[TBL] [Abstract][Full Text] [Related]
18. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
[TBL] [Abstract][Full Text] [Related]
19. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A
Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277
[TBL] [Abstract][Full Text] [Related]
20. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.
Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C;
JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
